Therefore it was suggested that chemotherapy-induced up-regulation of pEGFR and pERK reinforced the sensitivity of lung cancer cells to subsequently used EGFR-TKI, and finally resulted in improved outcomes. The gene discussed is EIF2AK3; the disease is lung cancer.